George Koutsoudakis, Inés Romero-Brey, Carola Berger, Gemma Pérez-Vilaró, Paula Monteiro Perin, Florian Wolfgang Rudolf Vondran, Markus Kalesse, Kirsten Harmrolfs, Rolf Müller, Javier P Martinez, Thomas Pietschmann, Ralf Bartenschlager, Mark Brönstrup, Andreas Meyerhans, Juana Díez
Journal of hepatology 2015 OctSoraphen A (SorA) is a myxobacterial metabolite that inhibits the acetyl-CoA carboxylase, a key enzyme in lipid biosynthesis. We have previously identified SorA to efficiently inhibit the human immunodeficiency virus (HIV). The aim of the present study was to evaluate the capacity of SorA and analogues to inhibit hepatitis C virus (HCV) infection. SorA inhibition capacity was evaluated in vitro using cell culture derived HCV, HCV pseudoparticles and subgenomic replicons. Infection studies were performed in the hepatoma cell line HuH7/Scr and in primary human hepatocytes. The effects of SorA on membranous web formation were analysed by electron microscopy. SorA potently inhibits HCV infection at nanomolar concentrations. Obtained EC50 values were 0.70 nM with a HCV reporter genome, 2.30 nM with wild-type HCV and 2.52 nM with subgenomic HCV replicons. SorA neither inhibited HCV RNA translation nor HCV entry, as demonstrated with subgenomic HCV replicons and HCV pseudoparticles, suggesting an effect on HCV replication. Consistent with this, evidence was obtained that SorA interferes with formation of the membranous web, the site of HCV replication. Finally, a series of natural and synthetic SorA analogues helped to establish a first structure-activity relationship. SorA has a very potent anti-HCV activity. Since it also interferes with the membranous web formation, SorA is an excellent tool to unravel the mechanism of HCV replication. Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
George Koutsoudakis, Inés Romero-Brey, Carola Berger, Gemma Pérez-Vilaró, Paula Monteiro Perin, Florian Wolfgang Rudolf Vondran, Markus Kalesse, Kirsten Harmrolfs, Rolf Müller, Javier P Martinez, Thomas Pietschmann, Ralf Bartenschlager, Mark Brönstrup, Andreas Meyerhans, Juana Díez. Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity. Journal of hepatology. 2015 Oct;63(4):813-21
PMID: 26070407
View Full Text